Back to Peptide Pedia
Metabolic & Weight
Limited Research

Fat Blaster

FATB

Combination lipolytic research blend.

Also known as: Lipolytic research blend

Research dose rangePer-formulation (research blends)
Route studiedIntramuscular / subcutaneous
Study durationPer-session or weekly
Storage2–8 °C reconstituted/solution

Overview

Fat Blaster refers to a combination research blend of lipolytic compounds studied together in fat-metabolism models.

Key research findings

A blended lipotropic research formulation rather than a single compound — typically combining fat-metabolism cofactors (such as L-carnitine, lipotropic agents, and B-vitamins). Studied as a combination approach to support fat metabolism and energy.

Mechanism of action

Combines multiple lipolytic agents studied for synergistic effects on fat mobilization and metabolic signaling.

Molecular information

WeightBlend (multiple components)
LengthMulti-ingredient formulation
TypeLipotropic combination blend

Composition varies by source; commonly includes lipotropic cofactors and carnitine.

Research applications

  • Lipolysis research
  • Combination-blend studies
  • Fat-metabolism investigations

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Per-session

    Intended to support fat-metabolism cofactor availability during a regimen.

  2. Ongoing

    Effects depend on the specific blend composition and overall protocol.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

Lipo-C

Overlapping lipotropic ingredients — avoid stacking duplicate components.

Use caution

L-Carnitine

Often already a blend component; avoid double-dosing.

Use caution

AOD-9604

Distinct fat-metabolism mechanism.

Compatible

Quality indicators

Verify composition

Because this is a blend, confirm the exact ingredients and concentrations on the label.

Clear solution

Injectable blends should be clear; some B-vitamin blends carry a characteristic color.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Tolerability depends on the specific ingredients; injection-site reactions are commonly reported for IM blends.
  • Limited controlled research exists on proprietary blends as combined products.

References & further reading

Lipotropic agents in fat metabolism (review)

Reviewlipotropicscombination formulations

Overview of lipotropic cofactors commonly combined in fat-metabolism research formulations.

Topics

lipolysisblendmetabolism

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Limited Research

Sparse published data; largely preliminary or anecdotal.

Quick reference
Dose rangePer-formulation (research blends)
RouteIntramuscular / subcutaneous
DurationPer-session or weekly
Storage2–8 °C reconstituted/solution
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue